Home » Topics » Nephrology, BioWorld Science

Nephrology, BioWorld Science
RSS

ZS Pharma seeks U.S. approval of ZS-9 for hyperkalemia

May 27, 2015

Daiichi Sankyo develops phosphate transporter inhibitors

May 22, 2015

Prostanoid EP2/3 agonist ONO-8055: a promising agent for underactive bladder

May 18, 2015

Angion Biomedica plans phase III trial of BB3 in delayed kidney graft function

May 18, 2015

Phosphate Therapeutics releases phase II results for PT-20 in hyperphosphatemia

May 8, 2015

Tenapanor fails to significantly reduce albuminuria in patients with CKD and type 2 diabetes

May 6, 2015

Recruitment initiated in phase II trial of CicloMulsion for acute kidney injury

April 28, 2015

Merck & Co. presents novel MR antagonists

April 16, 2015

Phase IIb trial of Nefecon for primary IgA nephropathy meets primary endpoint

April 14, 2015

Hydra Biosciences and Boehringer Ingelheim collaborate on TRP inhibitors for renal diseases

April 14, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.